ABM-1310

· ABM Therapeutics Shanghai Company Limited

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ABM-1310, covering 2024-05-21 to 2024-11-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ABM-1310 in Patients With BRAF V600-Mutant Advanced Solid Tumors [Phase 1]